Archive for CURE

My “Battle With” and “Victory Over” MS, by Preston Walker- Part 1

Posted in ALL ARTICLES, VICTORIES & SUCCESS STORIES with tags , , , , , , , , , , on April 7, 2009 by David Granovsky
Stem Cell Treatment Keeps Helping Multiple Sclerosis Patient

I started following the saga of Preston Walker and Richard Humphries in June 2008, just after they had returned from Costa Rica to receive Adult Stem Cells to treat their Multiple Sclerosis.

Both men felt improvement immediately after the stem cell treatment.  And they still seem to be doing well- almost 9 months after the treatment.  They are gaining a following among Multiple Sclerosis patients who are well aware of their exploits.  Both Preston and Richard have become  role models for others suffering from Multiple Sclerosis

And now, Preston was featured on his local Fort Worth/Dallas Television Station:

In 2001, Walker was diagnosed with multiple sclerosis, suffered from chronic fatigue, and began losing the use of his legs.

“I felt like my cognition was declining at a rapid pace,” Walker said. “I really felt at the end of last year that I wouldn’t be employed any longer because the cognition just wasn’t there.”

That feeling changed after his Adult Stem Cell therapy in Costa Rica:

For the first time ever, doctors took samples of their fat, drew stem cells from it, and reinjected it.  By the second injection the results were obvious.  The men had more energy than they’d had in years.  By the end of the treatment Humphries no longer needed a cane to walk.

The fatigue and leg problems were a thing of the past for Walker.  “I don’t suffer from any of those symptoms we talked about,” he said.  “The depression, the fatigue, the cognitive cloud¦ I mean it will still raise its ugly head occasionally, but it’s nowhere near everyday and every moment of everyday like it was.”

And hearing about Preston’s story is nice enough but read this part too:

Humphries admits there were risks in being test patients for the treatment.  “If we or somebody doesn’t become a guinea pig than how can that benefit others?” Humphries asked.

Since their treatment, dozens of others have followed in their footsteps to receive the benefits of stem cell transplants.

The full news story is here.

Preston and Richard’s Multiple Sclerosis blog is here.


Adult Stem Cells Are What Work

Posted in ALL ARTICLES, STEM CELLS IN THE NEWS with tags , , , , , , , , , on April 7, 2009 by David Granovsky

I think this Rep has been reading my blog and drinking the kool-aid! Only a few corrections to what he wrote. -dg


Adult Stem Cells Are What Work

by Rep. J. Randy Forbes, 04/07/2009

Prof. Ian Wilmut of Edinburgh University is hardly a household name. However, most people would recognize his Nobel-Prize-winning scientific development. Prof. Wilmut was the individual who led the team that created the cloned sheep Dolly and pioneered a technique many would want to use for a type of embryonic stem-cell research. His action resulted in both uproar and applause all over the world and was instrumental in bringing the discussion of cloning and stem-cell research from the laboratory to the dinner table.

For years, the moral and ethical issue of destroying human embryos for scientific experimentation has been the biggest argument against embryonic stem-cell research.

(besides causing tumors and severe rejection issues -dg)

But now there is a new argument against embryonic stem-cell research: science.

Just recently, President Obama signed an executive order lifting the ban on the use of federal funds for embryonic stem-cell research, an act based more on politics than it was on science. (Private funding for this research has never been banned.) His action reignited the contentious issue for many individuals in the U.S. — it also ignored the miracles we’ve seen in advancing science.

Adult stem-cells are derived from umbilical cords, wisdom teeth, amniotic fluid, and various tissues, and they don’t hold the same ethical concerns that stem-cells taken from human embryos do. Over the years, adult stem cells have resulted in 73 successful treatments

(it’s up to 130+ now – dg)

for various diseases like Alzheimer’s, Type 1 Diabetes, Parkinson’s, and various forms of cancer.

A U.S. doctor, Amid (Amit – dg) Patel, has used adult stem cells to successfully treat over 1,800 patients who suffered from severe heart failure, dramatically increasing their quality of life and chances of survival. Two years ago, I met a man named Stephen Sprague, who had been treated for leukemia through the use of adult stem cells taken from umbilical cord blood. There are success stories like Dr. Patel’s and Stephen Sprague’s scattered across the globe where individuals have been treated for their diseases by adult stem cells, and the hope for future breakthroughs seems limitless. On the other hand, despite millions of dollars of research, not one — not one — embryonic stem-cell trial has resulted in the successful treatment of a human patient.

Perhaps most incredibly, though, is the fact that scientists have just recently figured out how to reprogram adult stem cells

(actually adult skin cells but they are turned into iPS and some argue that they must pass through an adult stem cell state while doing so – dg)

to the point where they function exactly like an embryonic stem cell. These cells, called induced pluripotent stem cells (iPS), can do everything an embryonic stem cell is capable of, only without having to destroy a human embryo. Because of this development, there is likely no medical benefit that can come from embryonic stem-cell research that cannot be obtained from adult stem cells.

(this is way to broad a generalization.  how can we determine what we can learn from something unless it is studied? – dg)

IPS cells also have a greater advantage because they can be derived from a person’s own cells, so a patient’s body is less likely to reject the stem-cell treatment.

(while this is true, many IPS cells are from other peoples cells.  recent iPS cells come from foreskins of other people or allogenic cells as opposed to autologous cells – dg)

Science is truly outpacing the embryonic stem-cell debate. Scientists across the world who were once advocates of this research have reversed course. They overwhelmingly say the future of stem-cell research lies in iPS cells and adult stem cells. Dr. James Thompson, known as the father of embryonic stem-cell research, has said that “it’s probably the beginning of the end for that controversy.” In fact, even the sheep-cloning Prof. Wilmut has abandoned embryonic stem-cell experimentation saying that the use of iPS cells is “extremely exciting and astonishing” and shows more promise for the future.

Stem Cell Research Helps Saves Diabetes Patient’s Leg From Amputation | Adult Stem Cell Research

Posted in ALL ARTICLES, VICTORIES & SUCCESS STORIES with tags , , , , , , , on April 6, 2009 by David Granovsky

Stem Cell Research Saves Diabetes Patient’s Leg From Amputation

Posted 6 April, 2009 in Peripheral Artery Disease |

Victory for Adult Stem Cell Research- Saves a Man’s Leg

Tom Fisher already had his right leg amputated due to complications from Diabetes and he was in danger of losing his left leg as well. However, stem cell research in the form of Adult Stem Cells has saved his leg from amputation and have healed all his ulcers and infections and gangrene bringing back his leg to 94% normal.

Stem Cell Therapy- Clinical Trial in Charleston, South Carolina

Fisher, 84 years old was treated at Roper Hospital in South Carolina where there is an ongoing randomized stem cell research trial for a stem-cell therapy to treat critical limb ischemia, a result of Peripheral Artery Disease.

From the stem cell news article:

“That was astounding,” said Dr. Jeb Hallett, medical director at the Roper St. Francis Heart and Vascular Center. “The results have been amazing.”

Of the nine area patients participating, seven still have their limbs, Hallett said.

Approximately 70-80% Success in Saving a Leg

The trial is sponsored by Harvest Technologies, a stem cell research company in Massachusetts who are also sponsoring similar studies in India and Europe.  According to Dr. Hallett, 87.5% of the Indian patients were able to keep their legs while in Europe, the results are 70% were able to keep their legs.

Without stem cell treatment, in similar cases of Peripheral Artery Disease, 80% LOSE their legs.  So, a 70-80% success rate for this Adult Stem Cell treatment is wonderful.

Stem Cell Treatment Before Pigs Fly?

What is not so wonderful is the results of the trial are not due until 2012.  Only 3-4 more years?? Are you serious?  Can’t we wait longer to use our own stem cells to heal ourselves?

Medicare is very interested in this as the price of stem cell treatment is cheaper than that of an angioplasty or bypass and thus would save them millions of dollars if approved by the FDA.

So if I understand correctly:

  1. the stem cell treatment is cheaper than other alternatives (angioplasty or bypass) for Peripheral Artery Disease,
  2. the therapy is safer and less invasive (just simple injections using a syringe of stem cells into the legs),
  3. it has no side effects because it uses your own Adult Stem Cells,
  4. and is probably 60-70% more effective than any other intervention— but it won’t be available for at least 4 more years (and that is being very optimistic).

Think how many legs will be lost in that time.  Way to Go FDA- your silly rules of treating a person’s own stem cells as a drug is costing lives and limbs.

Other People Helped by Adult Stem Cells for their Peripheral Artery Disease

Stem Cells for Peripheral Artery Disease

via Stem Cell Research Helps Saves Diabetes Patient’s Leg From Amputation | Adult Stem Cell Research.

Groundbreaking Stem cell therapy Phase II trial on damage heart tissue treatment

Posted in ALL ARTICLES, STEM CELLS IN THE NEWS with tags , , , , , , , , , , on April 4, 2009 by David Granovsky

This is great news also…

but they have been treating MI with adult stem cells successfully in thailand, germany, china for almost 10 yrs now.  Catch UP! -dg


On March 30, Dr. Roger Gammon, a cardiologist with Austin Heart cardiology group treated the first patient in the world( a 58-year-old Central Texas man) enrolled in a groundbreaking Phase II study. It is one of the nation’s first hospitals to test the new therapy.

The stem cell treatment is administered intravenously and typically takes less than an hour to complete.

The Austin Heart Hospital is one of the 40 hospitals in the nation to conduct this groundbreaking adult stem cell trial, and they are excited enough to lead the way in this important research.

The aim of the study is to test the effectiveness and safety of  administering adult stem cells intravenously to repair damaged heart tissue after a heart attack.

patients are injected with donated adult stem cells from the bone marrow of others. The stems cells are purified by Osiris Therapeutics, Inc., which markets them as a product called Prochymal.

Prochymal is being evaluated for its ability to treat heart damage caused by a heart attack. The active ingredient in the new treatment is adult Mesenchymal Stem Cells (MSCs).  MSCs have the ability to develop into other types of cells and generate new tissue, including heart muscle.

Patients who are interested to participate in the study must receive the treatment within seven days of a heart attack.

Source: FoxBusiness

via Stem Cell Research Blog » Groundbreaking Stem cell therapy Phase II trial on damage heart tissue treatment.

Medical News: ACC: Stem Cell Treatment May Help Repair MI Damage – in Meeting Coverage, ACC from MedPage Today

Posted in ALL ARTICLES, VICTORIES & SUCCESS STORIES with tags , , , , , , , , , , , on April 4, 2009 by David Granovsky

This is great news from my alma mater…but they have been treating MI with adult stem cells successfully in thailand, germany, china for almost 10 yrs now.  Catch UP! -dg


ACC: Stem Cell Treatment May Help Repair MI Damage

By Todd Neale, Staff Writer, MedPage Today, Published: April 02, 2009

Reviewed by Zalman S. Agus, MD; Emeritus Professor

University of Pennsylvania School of Medicine. Earn CME/CE credit

ORLANDO, April 2 — An infusion of autologous bone marrow progenitor cells may improve outcomes for patients who suffer a severe myocardial infarction, a phase I study suggested.

Action Points:

* Explain to interested patients that the findings come from a phase I study, which is designed to assess safety and feasibility, not efficacy.

* Note that this study was published as an abstract and presented as a poster at a conference. These data and conclusions should be considered to be preliminary until published in a peer-reviewed journal.

Patients who received the highest doses of enriched CD34+ endothelial progenitor cells in the affected vessel had increased perfusion of the infarct at six months (P=0.01), according to Arshed Quyyumi, M.D., of Emory University in Atlanta.

This is the first study to find a dose response when using enriched progenitor cells to repair damage following an MI severe enough to cause ventricular remodeling, he said at the American College of Cardiology meeting here…

via Medical News: ACC: Stem Cell Treatment May Help Repair MI Damage – in Meeting Coverage, ACC from MedPage Today.

Diseased Cartilage Harbors Unique Migratory Progenitor Cells

Posted in ALL ARTICLES, STEM CELLS IN THE NEWS with tags , , , , , , , , , on April 3, 2009 by David Granovsky

jointsScienceDaily (Apr. 2, 2009) — A new study finds previously unidentified fibrocartilage-forming progenitor cells in degenerating, diseased human cartilage, but not in cartilage from healthy joints. The research, published in the April 3rd issue of the journal Cell Stem Cell, provides valuable insights into the reparative potential of cartilage and may lead to development of regenerative therapies for arthritis.

Osteoarthritis (OA) is an incurable degenerative disease caused by a progressive deterioration of the cartilage that cushions and protects joints. “OA is the most common musculoskeletal disease in the elderly and is likely to be the fourth-leading cause of disability by the year 2020,” explains senior study author Dr. Nicolai Miosge from Georg August University in Goettingen, Germany. “This is our motivation for the further exploration of OA treatment options, including regenerative cell biological therapy.”…

via Diseased Cartilage Harbors Unique Migratory Progenitor Cells.

Letters from Laura #1 – Autism, GI issues, chronic ear infections, breast cancer and Jenny McCarthy

Posted in ALL ARTICLES, Letters from Laura with tags , , , , , , , , , , , , on April 3, 2009 by David Granovsky


Dear David-

Two years ago, my son was 16 months old and having terrible GI issues and chronic ear infections. He only slept through the night 4 times. We had him vaccinated for his MMR and immediately following he was losing his speech. We took him to docs who told us to put him on a white flour diet, handed us lots of allergy drug samples, and told us to get tubes in his ears. i was so frustrated.

one day, my daughter put a puzzle piece into my laptop and it got stuck. My husband ran it over to a computer place for me, and had our son Walker. A man there was looking at Walker and began asking my husband questions….was he drinking milk, how was his speech, etc. He (Stan Kurtz) introduced my husband to his 5 year old very healthy son, and told him his son was diagnosed with autism at age 2 and severe autism at age 3. They said he would never be a functioning child.

Stan did research and then changed his sons diet, put him on anti-fungal medication and Valtrex (they say that autism is a combination of infections, viruses, metal toxicity and intestinal fungus.) I called him the next day and he spent 90 minutes on the phone with me. He shared with me what he fed his son. He never asked for anything, offered no controversial drugs, and suggested I get a pure form of Vitamin B12 called Methylcobalamin and get him started on that.

That day we started the diet (no wheat, grain, dairy, sugar) and that night my son slept through the night. The next night the same, and on Sunday, he began speaking. We went to an autism doc and started the B12 shots and his vocabulary tripled. His GI issues went away. He has never had an ear infection since. Now we keep him on this diet and it’s been over 2 years. His teachers have no idea there was ever an issue and he speaks like a 6 year old!

Stan works with over 2K families and started a school.  He also helped with the recovery of Jenny McCarthy’s son. i was talking to him one day and he asked about my health. He asked if i had any sisters or any history of breast cancer. I said no. He said that with all the families that he sees, there is an unusually high incidence of breast cancer, and the thought amongst docs is that the fungal issues contribute to breast cancer. The fungus tends to be the glue that holds cancer cells together.

Three weeks later, i was diagnosed with breast cancer.

I went through all the treatments, and I am doing great.  Stan has us all on a real detox program and we all follow the diet.

The reason I bring this long story up to you, is that there are thousands of families who are treating their children for autism with great results and you hear nothing about it. Jenny said she was expecting teams of medical doctors to bust down her door asking how she recovered her child from severe autism. Not one call.


Related links: